Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 22, 1999

View Archived Issues

Company Profile: Allelix

The relationship among ERT, cardiovascular disease and cancer

Amylin signs letter of intent for sale of Cabrillo division

Centocor: Q4 1998 highlights

ERT gel available in Canada

Biogen and Inhale enter agreement for pulmonary delivery of Avonex

Glaxo Wellcome issues new R&D pipeline

Activase for acute management of stroke approved in Canada

Noven, Novartis and Vivelle Ventures to join in promoting osteoporosis nasal spray

Alpharma and Ascent enter strategic alliance

Licensing partner sought for development of prohibitin gene-based cancer Rx, Dx

Available for licensing from OMRF: diagnostic and therapeutic agents for spondyloarthropathies

Polyol anti-Helicobacter pylori agents, compositions and use claimed by Takeda

Structurally novel antiinflammatory/antiallergic agents in the Astra pipeline

SangStat's Thymoglobulin launched in U.S.

Janssen patents structurally distinct gastric prokinetic agents

Peptidomimetic aspartyl protease inhibitors from Pharmacopeia for AD and malaria

Dual 5-HT1A antagonists and 5-HT reuptake inhibitors emerge from research at Vita-Invest

U.S. patent providing improved gene delivery vectors issued to GenVec

Patent covers Millennium process for identifying antimicrobial drug targets

FDA accepts NDA filing for Evacet

Antihypertensive effects of bradykinin agonist FR-190997 evaluated in animals

Renal protective effects of azelnidipine involve inhibition of AGE production

Zeneca seeks European approval for Zomig formulation using OraSolv technology

Liposome initiates phase I clinical trial of TLC-ELL-12

Ceresine shows positive results in phase II trial in stroke patients

FDA permits initiation of GlycoDesign's phase I/II study of GD0039 as chemoprotective agent

Serevent now available in Canada as a treatment for chronic obstructive pulmonary disease

AVI BioPharma presents data from preclinical study of Resten-NG in restenosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...